Brain structure and function in neurofibromatosis type 1: Current concepts and future directions

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 3, 2010, Pages 304-309

  Payne, Jonathan M ^a   Moharir, Mahendranath D ^a   Webster, Richard ^a   North, Kathryn N ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION DEFICIT DISORDER; BRAIN MAPPING; BRAIN MATURATION; BRAIN SIZE; COGNITION; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; IMAGE ANALYSIS; LEARNING DISORDER; NEUROANATOMY; NEUROFIBROMATOSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; WHITE MATTER;

BRAIN; CHILD; COGNITION DISORDERS; DIAGNOSTIC IMAGING; ENERGY METABOLISM; FOLLOW-UP STUDIES; HUMANS; NEUROFIBROMATOSIS 1; ORGAN SIZE; THALAMUS;

EID: 77649123796     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.179630     Document Type: Review

References (59)

1. Hyman SL, Shores EA, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005;65:1037-44.
2. Brewer VR, Moore BD, Hiscock M. Learning disability subtypes in children with neurofibromatosis. J Learn Disabil 1997;30:521-33.
3. North KN, Joy P, Yuille D, et al. Learning difficulties in neurofibromatosis type 1: the significance of MRI abnormalities. Neurology 1994;44:878-83.
4. Van Es S, North KN, McHugh K, et al. MRI abnormalities in children with NF1. Pediatr Radiol 1996;26:478-87.
5. Cutting LE, Cooper KL, Koth CW, et al. Megalencephaly in NF1: predominately white matter contribution and mitigation by ADHD. Neurology 2002;59:1388-94.
6. Steen RG, Taylor JS, Langston JW, et al. Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities. Am J Neuroradiol 2001;22:810-17.
7. Said SM, Yeh TL, Greenwood RS, et al. MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. Neuroreport 1996;7:1941-4.
8. Moore BD, Slopis JM, Jackson EF, et al. Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology 2000;54:914-20.
9. Greenwood RS, Tupler LA, Whitt JK, et al. Brain morphometry, T2-weighted hypertensities, and IQ in children with neurofibromatosis type 1. Arch Neurol 2005;62:1904-8.
10. Kesler SR, Haberecht MF, Menon V, et al. Functional neuroanatomy of spatial orientation processing in Turner syndrome. Cereb Cortex 2004;14:174-80.
11. Dubovsky EC, Booth TN, Vezina G, et al. MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1. Am J Neuroradiol 2001;22:190-5.
12. Kayl AE, Moore BD, Slopis JM, et al. Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. J Child Neurol 2000;15:90-6.
13. Billingsley RL, Schrimsher GW, Jackson EF, et al. Significance of planum temporale and planum parietale morphologic features in neurofibromatosis type 1. Arch Neurol 2002;9:616-22.
14. Billingsley RL, Slopis JM, Swank PR, et al. Cortical morphology associated with language function in neurofibromatosis type 1. Brain Lang 2003;85:125-39.
15. Cutting LE, Koth CW, Burnette CP, et al. Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1. J Child Neurol 2000;15:157-60.
16. Joy P, Roberts C, North KN, et al. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 1995;37:906-14.
17. Hynd GW, Semrud-Clikeman M, Lorys AR, et al. Brain morphology in developmental dyslexia and attention deficit disorder/ hyperactivity. Arch Neurol 1990;47:919-26.
18. Leonard CM, Voeller KK, Lombardino LJ, et al. Anomalous cerebral structure in dyslexia revealed with magnetic resonance imaging. Arch Neurol 1993;50:461-9.
19. Loftus WC, Tramo MJ, Thomas CE, et al. Three-dimensional quantitative analysis of hemispheric asymmetry in the human superior temporal region. Cereb Cortex 1993;3:348-55.
20. Hillis AE, Work M, Barker PB, et al. Re-examining the brain regions crucial for orchestrating speech articulation. Brain 2004;127:1479-87.
21. Nixon P, Lazarova J, Hodinott-Hill I, et al. The inferior frontal gyrus and phonological processing: an investigation using rTMS. J Cogn Neurosci 2004;16:289-300.
22. Poldrack RA, Wagner AD, Prull MW, et al. Functional specialization for semantic and phonological processing in the left inferior prefrontal cortex. Neuroimage 1999;10:15-35.
23. Leonard CM, Eckert MA, Lombardino LJ, et al. Anatomical risk factors for phonological dyslexia. Cereb Cortex 2001;11:148- 57.
24. Lopez Ferraz Filho JR, Munis MP, Souza AS, et al. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1. Pediatr Radiol 2008;38:305-10.
25. Sevick RJ, Barkovich AJ, Edwards MS, et al. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. Am J Roentgenol 1992;159:171-5.
26. Gill DS, Hyman SL, Steinberg A, et al. Age-related findings on MRI in neurofibromatosis type 1. Pediatr Radiol 2006;36:1048- 56.
27. DiMario FJ, Ramsby G, Greenstein R, et al. Neurofibromatosis type 1: magnetic resonance imaging findings. J Child Neurol 1993;8:32-9.
28. Hyman SL, Gill DS, Shores EA, et al. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology 2003;60:1139-45.
29. Dunn DW, Roos KL. MRI evaluation of learning difficulties and incoordination in neurofibromatosis type 1. Neurofibromatosis 1989;2:1-5.
30. Duffner PK, Cohen ME, Seidel FG, et al. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989;39:373-8.
31. Ferner RE, Chaudhuri R, Bingham J, et al. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatr 1993;56:492-5.
32. Bawden H, Dooley J, Buckley D, et al. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1. J Clin Exp Neuropsychol 1996;18:784-92.
33. Legius EM, Descheemaeker MJ, Steyaert J. Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. J Neurol Neurosurg Psychiatr 1995;59:638-40.
34. Moore BD, Slopis JM, Schomer D, et al. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996;46:1660-8.
35. Denckla MB, Hofman K, Mazzocco MMM, et al. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis type 1. Am J Med Genet 1996;67:98-102.
36. Hyman SL, Gill DS, Shores EA, et al. T2-hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. J Neurol Neurosurg Psychiatr 2007;78:1088-91.
37. Goh WHS, Khong P-L, Leung CSY, et al. T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function. J Child Neurol 2004;19:853-8.
38. Van der Werf YD, Scheltens P, Lindeboom J, et al. Deficits of memory, executive functioning and attention following infarctions in the thalamus; a study of 22 cases with localised lesions. Neuropsychologia 2003;41:1330-44.
39. Johnson MD, Ojemann GA. The role of the human thalamus in language and memory: evidence from electrophysiological studies. Brain Cogn 2000;42:218-30.
40. Billingsley RL, Jackson EF, Slopis JM, et al. Functional magnetic resonance imaging of phonologic processing in neurofibromatosis 1. J Child Neurol 2003;18:731-40.
41. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Functional disruption in the organization of the brain for reading in dyslexia. Proc Natl Acad Sci U S A 1998;95:2636-41.
42. Ben-Shachar M, Dougherty RF, Wandell BA. White matter pathways in reading. Curr Opin Neurobiol 2007;17:258-70.
43. Billingsley RL, Jackson EF, Slopis JM, et al. Functional MRI of visual-spatial processing in neurofibromatosis, type 1. Neuropsychologia 2004;42:395-404.
44. Clements-Stephens AM, Rimrodt SL, Gaur P, et al. Visuospatial processing in children with neurofibromatosis type 1. Neuropsychologia 2008;46:690-7.
45. Grigorenko EL. Developmental dyslexia: an update on genes, brains, and environments. J Child Psychol Psychiatry 2001;42:99-125.
46. Small SL, Flores DK, Noll DC. Different neural circuits subserve reading before and after therapy for acquired dyslexia. Brain Lang 1998;62:298-308.
47. Balestri P, Lucignani G, Fois A, et al. Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D- glucose and PET. J Neurol Neurosurg Psychiatr 1994;57:1479-83.
48. Kaplan AM, Chen K, Lawson MA, et al. Positron emission tomography in children with neurofibromatosis-1. J Child Neurol 1997;12:499-506.
49. Buchert R, von Borczyskovski D, Wilke F, et al. Reduced thalamic 18F-fluorodeoxyglucose retention in adults with neurofibromatosis type 1. Nucl Med Commun 2008;29:17-26.
50. Catani M, Ffytche DH. The rise and fall of disconnection syndromes. Brain 2005;128:2224-39.
51. Hagmann P, Jonasson L, Maeder P, et al. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics 2006;26:S205- 23.
52. LeBihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001;13:534-46.
53. Little DM, Holloway RG. Diffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture? Neurology 2007;68:9-10.
54. Nagy Z, Westerberg H, Klingberg T. Maturation of white matter is associated with the development of cognitive functions during childhood. J Cogn Neurosci 2004;16:1227-33.
55. Olesen PJ, Nagy Z, Westerberg H, et al. Combined analysis of DTI and fMRI data reveals a joint maturation of white and grey matter in a fronto-parietal network. Brain Res Cogn Brain Res 2003;18:48-57.
56. Deutsch GK, Dougherty RF, Bammer R, et al. Children's reading performance is correlated with white matter structure measured by diffusion tensor imaging. Cortex 2005;41:354-63.
57. Klingberg T, Hedehus M, Temple E, et al. Microstructure of temporo-parietal white matter as a basis for reading ability: evidence from diffusion tensor magnetic resonance imaging. Neuron 2000;25:493- 500.
58. Zamboni SL, Loenneker T, Boltshauser, et al. Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1. Am J Neuroradiol 2007;28:773-6.
59. van Engelen SJPM, Krab LC, Moll HA, et al. Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type 1 using diffusion tensor imaging. Am J Neuroradiol 2008;29:816-22.